Nurix Therapeutics (NRIX) Current Deferred Revenue (2019 - 2026)
Nurix Therapeutics' Current Deferred Revenue was $13.32 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 51.4% from $27.42 million a year earlier and down 29.0% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Current Deferred Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Current Deferred Revenue at Nurix Therapeutics came in at $17.58 million, down 54.2% from FY2024.
- Current Deferred Revenue shows a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- In earlier fiscal years, Current Deferred Revenue was $38.36 million in FY2024 (-20.2%), $48.1 million in FY2023 (+27.8%), $37.63 million in FY2022 (-8.7%) and $41.21 million in FY2021 (+25.7%).
- The fiscal Q2 2026 figure marks the lowest quarterly Current Deferred Revenue since fiscal Q4 2019.
- Compared with a year earlier, Current Deferred Revenue has declined for seven straight quarters, with an average decline of 29.4% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was fiscal Q3 2024 (growth of 49.8%); the worst was fiscal Q4 2025 (a decline of 54.2%).
- Per Business Quant data, NRIX's Current Deferred Revenue in the three fiscal quarters before Q2 2026 was $18.75 million (Q1 2026), $17.58 million (Q4 2025) and $25.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Nurix Therapeutics | 2.90 Bn | 275.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 8.61 Mn |
| May 31, 2026 | 13.32 Mn |
| Feb 28, 2026 | 18.75 Mn |
| Nov 30, 2025 | 17.58 Mn |
| Aug 31, 2025 | 25.99 Mn |
| May 31, 2025 | 27.42 Mn |
| Feb 28, 2025 | 30.59 Mn |
| Nov 30, 2024 | 38.36 Mn |
| Aug 31, 2024 | 48.00 Mn |
| May 31, 2024 | 46.77 Mn |
| Feb 29, 2024 | 46.08 Mn |
| Nov 30, 2023 | 48.10 Mn |
| Aug 31, 2023 | 32.04 Mn |
| May 31, 2023 | 44.06 Mn |
| Feb 28, 2023 | 38.31 Mn |
| Nov 30, 2022 | 37.63 Mn |
| Aug 31, 2022 | 36.34 Mn |
| May 31, 2022 | 41.32 Mn |
| Feb 28, 2022 | 43.19 Mn |
| Nov 30, 2021 | 41.21 Mn |
API Access
Nurix Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();